UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000013169 |
|---|---|
| Receipt number | R000015356 |
| Scientific Title | Phase I/II study of bortezomib plus Lenalidomide and dexamethasone (Once weekly VRd-21) for relapsed and/or refractory multiple myeloma (Once weekly VRd-21, I/II VRD for MM) |
| Date of disclosure of the study information | 2014/02/15 |
| Last modified on | 2016/02/22 10:57:55 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/02/15 00:24:09 | ||
| 2 | Update | 2014/09/23 01:14:51 | UMIN ID1 |
|
| 3 | Update | 2014/09/23 01:20:49 | Key inclusion criteria Key inclusion criteria Key exclusion criteria |
|
| 4 | Update | 2014/09/23 01:24:46 | ||
| 5 | Update | 2015/02/23 09:21:10 | Recruitment status |
|
| 6 | Update | 2015/09/19 16:49:48 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results |
|
| 7 | Update | 2015/09/19 16:58:18 | Control |
|
| 8 | Update | 2016/02/22 10:57:55 | Recruitment status Publication of results |
